FOXA2 and hereditary sensory and autonomic neuropathy: Immunostaining with DE markers SOX17 and FOXA2 further confirmed that a higher proportion of DE population in CILy and CIP condition, especially CIP, efficiently generated a near homogenous SOX17 and FOXA2 co-expressed DE population, which comparable with CA treatment as a control (Fig. 2C).